08:54 AM EDT, 08/15/2025 (MT Newswires) -- AstraZeneca ( AZN ) said Friday it launched its at-home delivery service for nasal spray flu vaccine FluMist.

The service, called FluMist Home, will be available in 34 states for the 2025-26 flu season, the company said, adding that it aims to make the service available in the 48 contiguous states in the future.

FluMist, which can be self-administered by people aged 18 to 49 or by a parent or caregiver to people aged two to 17, will remain available in doctors' offices and pharmacies for administration by health care professionals in the country, AstraZeneca ( AZN ) said.